INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,673,889 | -20.0% | 242,691 | +3.2% | 0.04% | -15.1% |
| Q2 2023 | $9,592,638 | +49.8% | 235,229 | +36.9% | 0.05% | +43.2% |
| Q1 2023 | $6,405,000 | -1.3% | 171,879 | -8.3% | 0.04% | -7.5% |
| Q4 2022 | $6,492,000 | -40.5% | 187,365 | -3.9% | 0.04% | -43.7% |
| Q3 2022 | $10,915,000 | +6.0% | 195,063 | -2.0% | 0.07% | +9.2% |
| Q2 2022 | $10,301,000 | -38.8% | 199,032 | -14.0% | 0.06% | -24.4% |
| Q1 2022 | $16,824,000 | -37.3% | 231,517 | +4.6% | 0.09% | -27.1% |
| Q4 2021 | $26,843,000 | -13.5% | 221,404 | -4.3% | 0.12% | -15.7% |
| Q3 2021 | $31,030,000 | -28.0% | 231,312 | -13.1% | 0.14% | -24.3% |
| Q2 2021 | $43,087,000 | – | 266,123 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |